Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2019-07-14 16:37:23 UTC |
---|
Last Updated | 2019-10-01 21:41:38 UTC |
---|
CypComp ID | CC02200 |
---|
Compound Information |
---|
Name | Trimipramine |
---|
Structure Image | |
---|
InChIKey | ZSCDBOWYZJWBIY-MRXNPFEDSA-N |
---|
PubChem ID | 5282594 |
---|
CypCompound Information |
---|
Set | CypBoM Training Set |
---|
Bonds of Metabolism (BoMs) | CYP1A2 | CYP2A6 | CYP2B6 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP2E1 | CYP3A4 | | | | | | - <21,20;Cleavage;R1>
- <21,H;Oxidation;R1>
- <22,20;Cleavage;R2>
- <22,H;Oxidation;R2>
| - <10,H;Hydroxylation;R1>
- <13,H;Hydroxylation;R2>
- <18,H;Hydroxylation;R3>
- <19,H;Hydroxylation;R4>
| | |
|
---|
References | - Eap CB, Bender S, Gastpar M, Fischer W, Haarmann C, Powell K, Jonzier-Perey M, Cochard N, Baumann P: Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patients. Ther Drug Monit. 2000 Apr;22(2):209-14. [PubMed:10774635 ]
- Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. [PubMed:19902987 ]
|
---|
Download File | CC02200.sdf |
---|